These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 602951)
1. The anticoagulant dilemma--a prescription for its resolution. Wessler S Am J Med Sci; 1977; 274(2):106-17. PubMed ID: 602951 [TBL] [Abstract][Full Text] [Related]
2. Antithrombotic drugs: part I. Gallus AS; Hirsh J Drugs; 1976; 12(1):41-68. PubMed ID: 789043 [TBL] [Abstract][Full Text] [Related]
3. [Indications of anticoagulant and fibrinolytic drugs in the prevention and therapy of thromboembolic diseases]. Verstraete M Clin Ter; 1975 Jun; 73(5):403-22. PubMed ID: 1139864 [No Abstract] [Full Text] [Related]
4. Beyond heparin and warfarin: the new generation of anticoagulants. Weitz JI; Linkins LA Expert Opin Investig Drugs; 2007 Mar; 16(3):271-82. PubMed ID: 17302522 [TBL] [Abstract][Full Text] [Related]
5. Heparin and warfarin: use of anticoagulants in the prevention and treatment of venous thrombosis and pulmonary embolism. Rosen RL J Fam Pract; 1979 May; 8(5):923-7. PubMed ID: 438753 [TBL] [Abstract][Full Text] [Related]
6. Anticoagulation drug therapy: a review. Harter K; Levine M; Henderson SO West J Emerg Med; 2015 Jan; 16(1):11-7. PubMed ID: 25671002 [TBL] [Abstract][Full Text] [Related]
7. [Inhibition of plasmatic coagulation: what is new?]. Schwarz M; Bode C Hamostaseologie; 2006 May; 26(2):154-7. PubMed ID: 16676059 [TBL] [Abstract][Full Text] [Related]
8. Treating patients with venous thromboembolism: initial strategies and long-term secondary prevention. Huisman MV; Bounameaux H Semin Vasc Med; 2005 Aug; 5(3):276-84. PubMed ID: 16123915 [TBL] [Abstract][Full Text] [Related]
10. A meta-analysis of thromboembolic prophylaxis following elective total hip arthroplasty. Freedman KB; Brookenthal KR; Fitzgerald RH; Williams S; Lonner JH J Bone Joint Surg Am; 2000 Jul; 82-A(7):929-38. PubMed ID: 10901307 [TBL] [Abstract][Full Text] [Related]
11. Role of current and emerging antithrombotics in thrombosis and cancer. Mousa SA Drugs Today (Barc); 2006 May; 42(5):331-50. PubMed ID: 16801996 [TBL] [Abstract][Full Text] [Related]
12. [Indications for and hazards of anticoagulant therapy]. Straub PW Schweiz Med Wochenschr; 1970 Apr; 100(16):686-91. PubMed ID: 4258885 [No Abstract] [Full Text] [Related]
13. Anticoagulants and Anticoagulation. Nussbaum M; Moschos CB Med Clin North Am; 1976 Sep; 60(5):855-69. PubMed ID: 781413 [No Abstract] [Full Text] [Related]
14. New anticoagulants. Linkins LA; Weitz JI Semin Thromb Hemost; 2003 Dec; 29(6):619-31. PubMed ID: 14719178 [TBL] [Abstract][Full Text] [Related]
15. Coumarin therapy in thrombosis. Pineo G; Hull RD Hematol Oncol Clin North Am; 2003 Feb; 17(1):201-16, viii. PubMed ID: 12627669 [TBL] [Abstract][Full Text] [Related]
16. [Indirect anticoagulants in the prevention of thromboembolic complications after myocardial infarction]. Sumin AN Kardiologiia; 2012; 52(4):68-73. PubMed ID: 22839519 [No Abstract] [Full Text] [Related]
17. Changing trends in anti-coagulant therapies. Are heparins and oral anti-coagulants challenged? Fareed J; Iqbal O; Cunanan J; Demir M; Wahi R; Clarke M; Adiguzel C; Bick R Int Angiol; 2008 Jun; 27(3):176-92. PubMed ID: 18506123 [TBL] [Abstract][Full Text] [Related]
18. Guide to anticoagulant therapy: Heparin : a statement for healthcare professionals from the American Heart Association. Hirsh J; Anand SS; Halperin JL; Fuster V; Circulation; 2001 Jun; 103(24):2994-3018. PubMed ID: 11413093 [No Abstract] [Full Text] [Related]
19. Anticoagulants: the state of the art. Gallus AS Aust Fam Physician; 1982 Jan; 11(1):14-22. PubMed ID: 7065989 [TBL] [Abstract][Full Text] [Related]
20. More than an anticoagulant: Do heparins have direct anti-inflammatory effects? Poterucha TJ; Libby P; Goldhaber SZ Thromb Haemost; 2017 Feb; 117(3):437-444. PubMed ID: 27975101 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]